Why the study?
Does the WANDA remote monitoring system improve vital sign control in patients with congestive heart failure?
Does the WANDA remote monitoring system improve vital sign control in patients with congestive heart failure?
The WANDA remote monitoring system may help CHF patients maintain vital signs within acceptable ranges.
May support remote monitoring for vital sign stability in CHF; leaves open confirmation in randomized trials.
Congestive heart failure (CHF) is a cardiovascular disorder that affects approximately 4.6 million Americans and is a leading cause of death in the United States. Current research shows that strategies to promote early recognition and treatment of symptoms and enhance self-care management behaviors reduce unnecessary hospitalizations. However, mechanisms to monitor patients' health status and behaviors are limited by constraints imposed by the patient's geography, infirmity, or resources. Remote monitoring supports a more dynamic connection between healthcare providers and patients, improves health promotion and patient care through monitoring of health data, communicates health reminders, and makes provisions for patient feedback. This paper will describe two versions of Weight and Activity with Blood Pressure Monitoring System (WANDA [22]) that leverages sensor technology and wireless communication to monitor health status of patients with CHF. The WANDA system is built on a three-tier architecture consisting of sensors, a web server, and back-end database tiers. The system was developed in conjunction with the UCLA School of Nursing and the UCLA Wireless Health Institute to enable early detection of key clinical symptoms indicative of CHF-related decompensation in a real-time automated fashion and allows health professionals to offer surveillance, advice, and continuity of care and triggers early implementation of strategies to enhance adherence behaviors. The small study has enabled patients to reduce or maintain the number of readings which are out of the acceptable range. For diastolic, systolic, and heart rate values, the t-test results show that the WANDA study is effective for patients with CHF.
No takes yet. Share an insight, caveat, or question.
Suh et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: